Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55)...
-
Upload
susanna-bradford -
Category
Documents
-
view
224 -
download
0
Transcript of Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55)...
![Page 1: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/1.jpg)
Breast cancer
![Page 2: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/2.jpg)
Etiology1. Increased exposure to estrogens:A)Estradiol-early menarche (<12), late menopause (>55)B)Estrone-overweight womenC)Xeno-estrogens (contraceptives-increase the risk of
breast cancer, cervical cancer and liver cancer, but decrease the risk of endometrial and ovarian cancer)
The three major naturally occurring estrogens in women are estrone (E1)-from fatty tissue, ovaries and adrenalsestradiol (E2)-from the ovaries, adrenals and peripheral conversion of E1estriol (E3)-from placenta and adrenals.
![Page 3: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/3.jpg)
Etiology
2. Lack of breast-feeding 3. Smoking4. Genetic factors:-BRCA1 or BRCA2 mutations*-Lynch syndromes-other yet unidentified genetic risk factors
*The estimated lifetime risk of developing breast cancer for women with BRCA1 or BRCA2 mutations is 40% to 85%.
![Page 4: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/4.jpg)
Etiology
5. Mouse mammary tumor virus
![Page 5: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/5.jpg)
1. Ductal invasive carcinoma 2. Lobular invasive carcinoma
3. Paget’s disease of the nipple
Histological classification of breast cancer-3 main types
![Page 6: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/6.jpg)
Detailed histologic classification of breast cancer-not to memorize
Carcinoma, NOS (not otherwise specified). Ductal.
Intraductal (in situ). Invasive with predominant intraductal component. Invasive, NOS 80% of all breast cancersComedo. Inflammatory. Medullary with lymphocytic infiltrate. Mucinous (colloid). Papillary. Scirrhous. Tubular. Other.
Lobular. In situ. Invasive with predominant in situ component. Invasive.
Nipple. Paget disease, NOS. Paget disease with intraductal carcinoma. Paget disease with invasive ductal carcinoma.
Undifferentiated carcinoma.
Phyllodes tumor. Sarcomas.Primary lymphomas.
![Page 7: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/7.jpg)
Diagnosis of breast cancer-inspection and palpation of the
breasts and axillae• Palpation is best done after the menstrual bleeding,
when the breasts are the softest
![Page 8: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/8.jpg)
Breast inspection and palpation-click on the video
![Page 9: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/9.jpg)
Diagnosis of breast cancer-imaging
• Main breast imaging procedures:1. Mammography2. Ultrasound-for denser breast tissue (younger women,
usually <35 yo)3. MRI- -//-
![Page 10: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/10.jpg)
Diagnosis of breast cancer-biopsy
• Breast tissue sample taking procedures:I. Fine needle aspiration-ABANDONED FOR FINAL
DIAGNOSISII. Core biopsy:1. Palpation guided core needle biopsy 2. Stereotactic core needle biopsy3. Ultrasound guided core needle biopsyIII. Surgical biopsy1. Incisional biospy2. Excisional biopsy
![Page 11: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/11.jpg)
Core biopsy needle or TruCut needle-click on the movie
![Page 12: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/12.jpg)
Biopsy types-click on the video
![Page 13: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/13.jpg)
Diagnosis of breast cancer-additional diagnostic tests
1. Pulmonary radiography (for lung metastases)2. Abdominal ultrasound (for liver metastases)3. Bone scintigraphy (for bone metastases)
![Page 14: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/14.jpg)
Treatment of breast cancer
1. Surgery2. Radiation therapy3. Chemotherapy4. Hormonal treatment5. Treatment with biological agents
![Page 15: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/15.jpg)
Surgery1. Modified radical mastectomy with lymphadenectomy2. Lumpectomy with lymphadenectomy-lumpectomy is appropriate for tumors generally less than
3 cm, except for smaller breasts, when esthetic results cannot be obtained
-not suitable for T4 tumors (fixed to the pectoral fascia, skin or inflammatory breast cancer)
Lymphadenectomy should be performed excising levels 1 and 2 of axillary lymph nodes
![Page 16: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/16.jpg)
Lymphatic drainage of breast cancer
![Page 17: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/17.jpg)
Lymphatic drainage of breast cancer
• Laterally: through the axillary lymph nodes (group 1-2-3 (3=subclavian)) -> supraclavicular lymph nodes
• Medially: through the internal mammary lymph nodes
![Page 18: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/18.jpg)
Sentinel node procedure• Allows identification of the first draining
lymph node1.Lymphoscintigraphy (Filtered Sulfur Colloid
tagged with the radionuclide Technetium-99m)
2.Methylene blue dye
![Page 19: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/19.jpg)
Radiotherapy
• Adjuvant after lumpectomy for the remaining breast
• Adjuvant for the axilla and supraclavicular lymph nodes, if certain risk factors are present
![Page 20: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/20.jpg)
Chemotherapy
• For almost all breast tumors larger than 2 cm• Increases cure rates• Given neoadjuvantly for large tumors
frequently allows for ulterior lumpectomy
![Page 21: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/21.jpg)
Hormonal treatment
• Given for patients with tumors with positive hormone receptors (estrogen and/or progesterone)
• It needs to be given for more than 5 years• 3 main types of hormonal treatments:1.LHRH receptor agonists2.Aromatase inhibitors3.Tamoxifen
![Page 22: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/22.jpg)
1. LHRH (LH releasing hormone) receptor agonists
• act in the pituitary gland
• act first as agonists and create an LH surge, but block the LHRH receptors and thus decrease LH secretion and thus ovarian estradiol
![Page 23: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/23.jpg)
2. Aromatase inhibitors
• Inhibit the formation of estradiol in the ovaries
![Page 25: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/25.jpg)
3. Tamoxifen
• Partial antagonist and agonist • Antagonist on estrogen receptors from breast
tissue
• Agonist on estrogen receptors from bone=> no osteoporosis is produced as with the first 2 treatments
![Page 26: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/26.jpg)
Biologic treatments
• Herceptin=monoclonal antibody that blocks the HER2/neu growth factor receptor
• It is over-expressed in aprox. 30% of early breast cancers
![Page 27: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/27.jpg)
Reconstructive surgery
I. Immediate (at the time of the mastectomy)-musculo-adipose flapsII. Delayed-musculo-adipose flaps-submuscular silicone gel-/saline-filled implants
after stretching the overlying tissue with a tissue-expander over a period of weeks/months
![Page 28: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/28.jpg)
Follow-up• Evidence from randomized trials indicates that periodic
follow-up with bone scans, liver sonography, chest x-rays, and blood tests of liver function does not improve survival or quality of life when compared to routine physical examinations.
• Based on these data, some investigators recommend that acceptable follow-up be limited to physical examination and annual mammography for asymptomatic patients who complete treatment for stage I to stage III breast cancer.
The risk of a primary breast cancer in the contralateral breast is approximately 1% per year.
![Page 29: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/29.jpg)
Screening of breast cancerScreening of breast cancer with mammography
decreases breast cancer mortality*• For medium risk women:- Mammography from age 40, indefinitely,
annually [American Cancer Society American College of Radiology (ACR), Society of Breast Imaging (SBI)]
- OR: Mammography age 50->74, biannually [US Preventive Services Task Force (USPSTF) ]
• For high risk women (BRCA1 or BRCA2 mutation carriers or untested first-degree relatives of a BRCA mutation carrier) :
- Mammography from age 30
* 2009 Cochrane review estimated that mammography resulted in a relative risk reduction of death from breast cancer of 15% or an absolute risk reduction of 0.05%
![Page 30: Breast cancer. Etiology 1. Increased exposure to estrogens: A)Estradiol-early menarche ( 55) B)Estrone-overweight women C)Xeno-estrogens (contraceptives-increase.](https://reader034.fdocuments.net/reader034/viewer/2022051316/5697c0081a28abf838cc6cda/html5/thumbnails/30.jpg)
Questions
1. Which are the etiologic factors (risk factors) of breast cancer?
2. Which are the steps of diagnosis of breast cancer?3. What are the main types of treatment of breast cancer?4. What is the screening procedure for breast cancer and
when should it be started?